A leak that has been contaminating groundwater for several years at Goldcorp’s (NYSE: GG) Penasquito gold mine in Mexico, but that remained unpublicized until Reuters recently revealed its existence, is now part of an investigation by authorities to see if the mining company broke any environmental laws.
Articles by guudvans
To no one’s surprise, HP Inc. (NYSE: HPQ) reported a decline in total revenue in its recently released fiscal third quarter earnings report. The upside is that the $11.9 billion in sales — amounting to a 4% drop compared to the year-ago period — was better than expected by a wide margin.
It’s beginning to feel as though Oracle (NYSE: ORCL) is spending as much time in the courtroom as the boardroom. Currently at the top of its docket: Oregon v. Oracle. In the original case between the tech giant and Oregon, the state claimed that the botched creation of the Cover Oregon heath insurance exchange website — a $240 million fiasco that never reached fully operational status — was founder Larry Ellison and team’s fault.
In light of its recent acquisition activity, Pfizer’s (NYSE: PFE) latest asset purchase might seem small, but it’s nevertheless significant. The company has agreed to pay up to nearly $1.6 billion to purchase several antibiotics assets from AstraZeneca (NYSE: AZN).
When your studio management greenlights Ben-Hur, one of the biggest bombs of 2016, it’s reasonable to think your parent company may have some questions to ask. That’s exactly what’s happening with Paramount, which released a remake of the classic picture that failed to click with audiences on an epic level.
21st Century Fox’s (NASDAQ: FOX) (NASDAQ: FOXA) film division is getting its new chairman and CEO ahead of schedule: Prominent longtime movie executive Stacy Snider will take the reins at its Twentieth Century Fox studio effective Sept. 1. Snider had already been slated to replace Jim Gianopulos, who has been the subsidiary’s chairman and CEO for 16 years, and worked at the studio for a quarter of a century.
An Indian textiles manufacturer may soon find itself hard pressed to remain in business now that Bed Bath & Beyond (NASDAQ: BBBY) has become the latest retailer to launch an investigation into goods it was sold by it that may have been misrepresented.